COc1ccccc1-c1c[nH]nc1-c1ccc(OCc2ccc([N+](=O)[O-])cc2)cc1O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?